Conference presentation
Logotype for Octave Specialty Group Inc

Octave Specialty Group (OSG) Conference presentation summary

Event summary combining transcript, slides, and related documents.

Logotype for Octave Specialty Group Inc

Conference presentation summary

14 Nov, 2026

Business model and strategy

  • Dual-engine platform combines specialty insurance distribution acquisitions with de novo MGA launches; target 2–4 new ventures annually.

  • Partnership model aligns founders through retained ownership and profit participation, while providing technology, data infrastructure and integration support.

  • Organic growth priorities include new products and geographies, distribution expansion, cross-selling, carrier partnerships, and scalable data and technology.

  • De novo MGAs are generally structured to reach profitability within 18–24 months; recent 2024–2025 launches are expected to scale between 2026 and 2028.

Growth and portfolio

  • Insurance Distribution revenue rose from $55M in FY2023 to $101M in FY2025; organic revenue growth was 18% in 2024 and 55% in 2025.

  • 1H2026 Insurance Distribution revenue grew 85% to $137M, with 43% organic growth; segment adjusted EBITDA to shareholders was $35M versus $9.6M, and margin was 25.7% versus 13.0%.

  • Gross premiums placed reached $952M in 2025 and $741M in 1H2026 for Insurance Distribution; total revenue was $251M in 2025.

  • The pro forma MGA portfolio is diversified across Specialty P&C (74%) and Specialty A&H (26%); distribution spans 13 U.S.-based and 9 London/Bermuda-based MGAs.

  • 2028 adjusted EBITDA aspiration exceeds $80M, implying a stated CAGR of more than 40% from 2024A.

Capacity and underwriting

  • Available third-party capacity exceeded $2.0B in 1H2026; the majority is described as long-term and scalable.

  • Everspan reported a 97.1% adjusted combined ratio and 58.6% adjusted loss ratio for 1H2026; adjusted EBITDA to shareholders was $3.4M versus $2.3M.

  • Everspan holds an AM Best Financial Strength Rating of A- (Excellent) and targets mid-teens ROE at scale with a fee-focused strategy and managed risk exposure.

  • Consolidated 1H2026 revenue was $187M, up 59% YoY; adjusted EBITDA to shareholders was $24M versus a $6M loss in 1H2025.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Octave Specialty Group